ctrl K

Watchlist Price Alert

PMV Pharmaceuticals Inc. (PMVP)

NASDAQ: PMVP · Real-Time Price · USD

0.85

-0.00 (-0.26%)

At close: May 14, 2025, 3:54 PM

0.98

14.62%

After-hours: May 14, 2025, 06:51 PM EDT

PMV Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.14M	1.26M	650K	1.28M	318K	388K	338K
Gross Profit	n/a	-1.26M	-650K	-1.28M	-318K	-388K	-338K
Operating Income	-85.45M	-80.13M	-77.04M	-58.29M	-34.94M	-26.64M	-18.89M
Interest Income	n/a	11.17M	3.63M	449K	651K	1.3M	1.34M
Pretax Income	-74.81M	-68.96M	-73.33M	-57.82M	-34.43M	-25.34M	-17.54M
Net Income	-58.71M	-68.96M	-73.32M	-57.85M	-34.44M	-25.35M	-17.54M
Selling & General & Admin	26.92M	24.25M	25.05M	21.8M	11.01M	5.88M	5.04M
Research & Development	58.53M	54.63M	51.99M	36.49M	23.93M	20.76M	13.85M
Other Expenses	n/a	n/a	87K	21K	-143K	-8K	16K
Operating Expenses	85.45M	80.13M	77.04M	58.29M	34.94M	26.64M	18.89M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	80.13M	77.04M	58.29M	34.94M	26.64M	18.89M
Income Tax Expense	-16.1M	2K	-9K	23K	6K	8K	3K
Shares Outstanding (Basic)	51.58M	48.01M	45.59M	45.14M	44.78M	43M	31.23M
Shares Outstanding (Diluted)	51.58M	48.01M	45.59M	45.14M	44.78M	43M	31.23M
EPS (Basic)	-1.14	-1.44	-1.61	-1.28	-2.4	-0.59	-0.56
EPS (Diluted)	-1.14	-1.44	-1.61	-1.28	-2.4	-0.59	-0.56
EBITDA	-73.67M	-78.88M	-76.72M	-57.99M	-34.62M	-26.25M	-18.55M
EBIT	-74.81M	-80.13M	-77.04M	-58.29M	-34.94M	-26.64M	-18.89M
Depreciation & Amortization	1.14M	1.26M	650K	1.28M	318K	388K	338K